Market Share of United States Insulin Drugs And Delivery Devices Industry
The United States Insulin Drugs and Delivery Devices Market is consolidated, with few significant and generic players. Recently, mergers and acquisitions between the players have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.
US Insulin Drugs & Delivery Devices Market Leaders
Novo Nordisk
Medtronics
Sanofi
Eli Lily
Ypsomped
*Disclaimer: Major Players sorted in no particular order
